Use of a DPP-IV inhibitor to reduce hypoglycemic events

Details for Australian Patent Application No. 2011202574 (hide)

Owner Novartis AG

Inventors Balkan, Bork; Holmes, David Grenville; Hughes, Thomas Edward; Villhauer, Edwin Bernard

Agent Davies Collison Cave

Pub. Number AU-B-2011202574

Parent 2006292377

Filing date 1 June 2011

Wipo publication date 23 June 2011

Acceptance publication date 2 February 2012

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

16 June 2011 Complete Application Filed

23 June 2011 Application Open to Public Inspection

  Published as AU-B-2011202574

2 February 2012 Application Accepted

  Published as AU-B-2011202574

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202575-Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants

2011202573-Direct compression formulation of DPPIV inhibitors and glitazones, and process